Table 1 Clinical data on patients used in the study.
Cohort characteristics | |||
|---|---|---|---|
Sjögren's syndrome | Healthy controls | ||
Number | n = 12 | n = 5 | |
Age in years (mean +/- SD) | 50 +/-13 | 45 +/-7 | |
Range | 33-71 | 34-52 | |
Female:male | 12:0 | 5:0 | |
Time since diagnosis in years (mean +/- SD) | 8.5 +/- 4.1 | ||
Clinical features | |||
Anti-Ro | 10/12 | ||
Anti-La | 5/12 | ||
Both anti-Ro and anti-La | 5/12 | ||
No anti-Ro and anti-La | 2/12 | ||
Rheumatoid factor | 4/12 | ||
Anti-ribonucleoprotein | 1/12 | ||
Focus score | |||
FS:0 | 3/12 | ||
FS:1 | 2/12 | ||
FS:2 | 5/12 | ||
FS:3 | 0/12 | ||
FS:4 | 2/12 | ||
FS:5 | 0/12 | ||
Treatment | |||
Antimalarial | 4/12 | ||
Methotrexate | 1/12 | ||
Extraglandular manifestations | 8/12 | ||
Hypothyriodism | 2/12 | ||
Polyarthritis | 2/12 | ||
Exanthema | 2/12 | ||
Polyneuropathy | 1/12 | ||
Pulmonary embolism | 1/12 |